Treatment for paraganglioma with stereotactic radiotherapy

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 16

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Jun 6, 2024; 12(16): 2729-2737
Published online Jun 6, 2024. doi: 10.12998/wjcc.v12.i16.2729

Table 3 Summary of patient outcome

OS: Overall survival; PFS: Progression free survival; PD: Progression disease; PR: Partial response; NA: Not available.

Citation: Pontoriero A, Critelli P, Zeppieri M, Angileri FF, Ius T. Treatment for paraganglioma with stereotactic radiotherapy. World J Clin Cases 2024; 12(16): 2729-2737
URL: https://www.wjgnet.com/2307-8960/full/v12/i16/2729.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i16.2729

Pontoriero A, Critelli P, Zeppieri M, Angileri FF, Ius T. Treatment for paraganglioma with stereotactic radiotherapy. World J Clin Cases 2024; 12(16): 2729-2737 [PMID: 38899289 DOI: 10.12998/wjcc.v12.i16.2729]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.